NTI 1.19% 8.3¢ neurotech international limited

Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial, page-4

  1. 732 Posts.
    lightbulb Created with Sketch. 158
    Ticking another box, eventually the market will take notice.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.